Janice Lu MD PhD ABRCC

    Clinical Researchers Showcase Series - May 2016

    Translational Medicine Research:

 View from the Trenches Newsletter

box_top.gif

Brought to you by:

Criterium Logo Alt Tag Line w Globe Banner 2

Translational science is motivated by the need to provide effective treatments to the right patients at the right doses for a specific disease indication). The term is used mostly in the health sciences and refers to real-time translation of bench science, conducted

only in a lab, to bedside clinical practice or dissemination

to population-based community interventions.

-  Source: NIH -- Read more


from the
Academic Breast Cancer Consortium

ABRCC Researcher Spotlight:

MEET Dr. Janice Lu, M.D., Ph.D.
USC Norris Comprehensive Cancer Center,
Los Angeles, CA  --  ABRCC Investigator


Janice Lu, MD, PhD is Professor of Medicine and Associate Director of Breast Cancer Research at USC Norris Comprehensive Cancer Center, as well as Breast Cancer Clinical Trials Director, Division of Medical Oncology

 

Dr. Janice Lu graduated from Beijing University School of Medicine and completed her Hematology and Medical Oncology fellowship at New York University School of Medicine. She earned her PhD degree from Syracuse University, NY, in Molecular Biology with Dr. David Allis, a pioneer in the foundations of epigenetics at Rockefeller University. She has recently been at UCLA's Division of Hematology and Oncology as Associate Professor of Medicine , and has previously served as the Director of the Breast Medical Oncology Program at State University of New York at Stony Brook for eight years.

See Dr Lu's Online Profile


She has extensive experience in clinical trials, breast cancer drug development and has led studies as national protocol chair. Her goal is to utilize her science and medical knowledge to work with each patient on a highly individualized basis with state-of-the-art cancer care.

 

About USC Norris Comprehensive Cancer Center Medicine


 The USC Norris Comprehensive Cancer Center, located in Los Angeles, is a major regional and national resource for cancer research, treatment, prevention and education. More than 200 basic and population scientists, physicians from the faculty of the Keck School of Medicine of USC and several USC professional schools/departments and the College of Letters, Arts and Sciences who are members of the USC Norris Comprehensive Cancer Center investigate the complex origins and progression of cancer, develop prevention strategies and search for cures. The National Cancer Institute (NCI) has designated the USC Norris Comprehensive Cancer Center as one of the nation's 41 comprehensive cancer centers, a select group of institutions providing leadership in cancer treatment, research, prevention and education. USC Norris Comprehensive Cancer Center has held this designation since 1973, when it was named as one of the first eight comprehensive cancer centers. Learn more at http://uscnorriscancer.usc.edu

box_bottom.gif

About the CONSORTIA MODEL 
for Translational Research

The important conceptual difference between the two predominant research group approaches used today (a Clinical Trials Group vs. Consortia) is seen in this consortia model.  With its highly experienced clinical scientists, ABRCC becomes involved on an intellectual advisory level with every step of clinical investigation in a breast cancer study. Classical clinical trials groups "just run the study" with the main substantive role being patient accrual.

 

To read more on ABRCC and the details of why the consortia model creates fast results, please visit our website.


The Oncology Consortia of Criterium

The Oncology Consortia of Criterium Global CRO are a collaboration of outstanding Cancer Research Consortia that deliver innovative research and unparalleled expertise:

  • AGICC:  Academic GI Cancer Consortium
  • AMyC:  Academic Myeloma Consortium
  • ATOMIC:  Academic Thoracic Oncology Medical Investigators Consortium
  • ABRCC:  Academic Breast Cancer Consortium

ABRCC Cube FULL Logo 2

Read more about Criterium Inc Global CRO

and The Oncology Consortia of Criterium on our website